← Back to Search

Biliary Dilation Cohort for Association between Opiate Use and Biliary Dilation

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 hours
Awards & highlights

Summary

We hope to better define the association between opiate use and biliary dilation, which was evident in our previous retrospective study. This prospective study including all endoscopic ultrasound procedures performed for further evaluation of biliary dilatation in the setting of bilirubin \<2 mg/dL will enable accurate measurement of common bile duct and pancreatic duct diameter using endoscopic ultrasound and identification of other non- obstructive factors which may modulate biliary dilation (i.e. age, cholecystectomy status, duration and type of opiate used).

Eligible Conditions
  • Association between Opiate Use and Biliary Dilation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Identification of factors associated with biliary dilation
Identification of factors associated with pancreatic duct dilation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Biliary Dilation CohortExperimental Treatment1 Intervention
Patients referred for endoscopic evaluation of biliary dilation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Endoscopic ultrasound
2014
N/A
~140

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,455 Previous Clinical Trials
17,494,276 Total Patients Enrolled
~13 spots leftby Sep 2025